Condensed Consolidated Statements of Stockholders' Deficit (Unaudited)) - USD ($)	Total	Series A Preferred Stock	Series B Preferred Stock	Common Stock $0.001 Par Value	Paid-In Capital	Shares Payable	Accumulated Deficit
Balance, shares at Dec. 31, 2020				66,366,419
Balance, amount at Dec. 31, 2020	$ (5,705,452)	$ 0	$ 0	$ 66,366	$ 4,708,323	$ 645,192	$ (11,125,333)
Common stock issued for debt conversion, shares				3,086,420
Common stock issued for debt conversion, amount	614,198	0	0	$ 3,087	611,111	0	0
Common stock issued for deferred finance cost, shares				200,000
Common stock issued for deferred finance cost, amount	72,000	0	0	$ 200	71,800	0	0
Sale of common stock units, shares				2,479,994
Sale of common stock units, amount	187,800	0	0	$ 2,480	322,195	(136,875)	0
Common stock and warrants issued for settlement of notes payable, shares				414,930
Common stock and warrants issued for settlement of notes payable, amount	141,118	0	0	$ 415	140,703	0	0
Net loss	(8,682)	0	0	$ 0	0	0	(8,682)
Balance, shares at Mar. 31, 2021				72,547,763
Balance, amount at Mar. 31, 2021	(4,699,018)	$ 0	$ 0	$ 72,548	5,854,132	508,317	(11,134,015)
Balance, shares at Dec. 31, 2021		2,800,000	2,000,000	74,490,147
Balance, amount at Dec. 31, 2021	(4,514,303)	$ 259,422	$ 0	$ 74,490	6,210,414	331,600	(11,130,807)
Net loss	29,384						29,384
Issuance of Series B Preferred Stock, net of fees, shares			1,000,000
Issuance of Series B Preferred Stock, net of fees, amount	890,000	0	$ 100	$ 0	889,900	0
Common Stock and Warrants issued in connection with preferred stock, shares				76,490,147
Common Stock and Warrants issued in connection with preferred stock, amount				$ 2,000	(2,000)
Dividends on Series A Preferred Stock, amount	(22,833)	$ 3,107	$ 0	$ 0	(22,833)	0	0
Balance, shares at Mar. 31, 2022		2,800,000	1,000,000	76,490,147
Balance, amount at Mar. 31, 2022	$ (3,617,752)	$ 262,529	$ 100	$ 76,490	$ 7,075,481	$ 331,600	$ (11,101,423)